| Campany et al.[40]
|
2022 |
NR |
C: 2 |
| Jordan et al.[43]
|
2022 |
21 mitral IE, 12 tricuspid IE, 10 aortic IE, 2 pulmonary IE |
A: 5, B: 14, D: 57 |
| Lopez-Vilella et al.[12]
|
2022 |
200 TR (moderate-to-severe) |
B: 1, C: 1, D: 196 |
| Martinez-Sellés et al.[44]
|
2021 |
4 aortic, 4 mitral, 3 tricuspid, 1 pulmonary valve endocarditis |
B: 1, D: 11 |
| Nersesian et al.[52]
|
2021 |
1 MS (severe) |
C: 1 |
| Roth et al.[11]
|
2021 |
2 TR (severe) |
C: 2 |
| Wallen et al.[15]
|
2020 |
1 AS (severe) |
C: 1 |
| Wosten et al.[53]
|
2020 |
1 TR |
C: 1 |
| Avula et al.[32]
|
2019 |
1 AS (severe) |
C: 1 |
| Bishawi et al.[13]
|
2019 |
114 moderate and severe TR, 428 no/trace/mild TR |
B: 6, D: 536 |
| Farag et al.[22]
|
2019 |
6 MR, 10 TR |
A: 1, B: 16 |
| Kremer et al.[54]
|
2019 |
1 MS |
B: 1 |
| Salas et al.[25]
|
2019 |
2 MR (severe) |
C: 2 |
| Akleh et al.[31]
|
2018 |
1 AS |
C: 1 |
| Jandhyala et al.[46]
|
2018 |
1 AR (moderate) with MR (severe) |
B: 1 |
| Goekler et al.[33]
|
2017 |
2 AS, 1 MS, 1 MR, 3 TR |
A: 10, B: 7 |
| Margale et al.[35]
|
2017 |
1 AS (severe) |
C: 1 |
| Stephens et al.[55]
|
2017 |
1 AR (moderate) |
A&B: 1* |
| Kyranis et al.[34]
|
2016 |
1 AS (severe) |
C: 1 |
| Gopalamurugan et al.[41]
|
2014 |
1 AR |
C: 1 |
| Holmes et al.[6]
|
2014 |
1 AS, 3 AR, 2 MR, 5 TR |
A: 12, B: 10 |
| Unic et al.[29]
|
2013 |
1 aortic valve endocarditis with severe AR |
B: 1 |
| Vollroth et al.[56]
|
2013 |
1 MR |
B: 1 |
| Zanuttini et al.[30]
|
2013 |
1 AR (severe) |
C: 1 |
| Elhenawy et al.[28]
|
2012 |
1 AR (severe) with aortic root and ascending aorta aneurysm |
A: 1 |
| Bruschi et al.[37]
|
2010 |
1 AS (severe) |
C: 1 |
| Goerler et al.[19]
|
2010 |
1 IE (aort + mitral + tricuspid), 1 AR, 2 MR, 20 TR |
A: 23 B: 25 |
| Seiffert et al.[36]
|
2010 |
1 AS (severe) |
C: 1 |
| Joyce et al.[38]
|
2009 |
1 mild-to-moderate AR, moderate AS |
B: 1 |
| Chen et al.[27]
|
2008 |
1 severe AR with dilation of aortic root |
A&B: 1* |
| Morio et al.[45]
|
2008 |
1 IE (mitral) |
D: 1 |
| Wigfield et al.[23]
|
2008 |
1 moderate/severe MR with moderate TR |
B: 1 |
| Roig et al.[50]
|
2007 |
2 AR, 6 MR, 12 TR |
B:1, C:2 |
| Management Category A: Cardiac surgery excluding retransplant and valve surgery; B: Valve surgery; C: Non-surgical intervention; D: Conservative management; NR: Not reported; IE: Infective endocarditis; TR: Tricuspid regurgitation; MS: Mitral stenosis; AS: Aortic stenosis; MR: Mitral regurgitation; AR: Aortic regurgitation; * The case had a non-valve cardiac surgery and a valve surgery at the same time. |
